$112,462,142

Funds the Alliance NCORP research base to support National Cancer Institute cooperative group clinical trials and cancer research infrastructure.

NCORP networks are critical for conducting large-scale, multi-institutional cancer clinical trials that generate evidence for FDA approvals and standard-of-care treatments.

Supports demand for clinical research services, biostatistics, data management, and pharmaceutical trial support across academic medical centers.

U.S. cancer research leadership depends on robust clinical trial networks; China is expanding its own oncology research capabilities and trial infrastructure.